Please login to the form below

Not currently logged in
Email:
Password:

Trobalt

This page shows the latest Trobalt news and features for those working in and with pharma, biotech and healthcare.

GSK/ Valeant's Trobalt set for EU restrictions

GSK/ Valeant's Trobalt set for EU restrictions

GSK/ Valeant's Trobalt set for EU restrictions. Eye concerns prompt CHMP to recommend last-line use for the epilepsy drug. ... European regulatory advisors have recommended GlaxoSmithKline and Valeant's epilepsy drug Trobalt be restricted after safety

Latest news

  • Eisai launches epilepsy drug Fycompa in UK

    Comparing uptake, however, both Zebinix and Vimpat had slow starts before achieving fast acceleration, whereas uptake for Trobalt was “ very, very slow” according to Hendler.

  • Therapy focus: Epilepsy

    In May 2011, GlaxoSmithKline launched its new epilepsy medicine Trobalt in the UK.

  • FDA approves GSK/Valeant anti-seizure drug

    In the EU, ezogabine is known as retigabine (Trobalt). The drug received marketing authorisation in the EU in March 2011.

  • GSK launches first-in-class epilepsy drug

    GSK launches first-in-class epilepsy drug. GSK introduces Trobalt for the adjunct treatment of adults with partial-onset seizures. ... GlaxoSmithKline (GSK) has launched Trobalt (retigabine), the first in a new class of anti-epileptic drug (AED), for the

  • GSK sales fall for first quarter of 2011

    Recent approvals for GSK include lupus drug Benlysta (belimumab), Horizant (gabapentin enacarbil) for Restless Legs Syndrome and epilepsy treatment Trobalt (retigabine).

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics